Plasma amine oxidase: a postulated cardiovascular risk factor in nondiabetic obese patients.
Increased activity of semicarbazide-sensitive plasma amine oxidase (SSAO), an enzyme converting various amines, has been implicated in the generation of endothelial damage through formation of cytotoxic reaction products. We investigated if SSAO activity is elevated in morbidly obese patients, which might contribute to the increased cardiovascular risk associated with obesity. SSAO activity was determined in 74 nondiabetic, obese patients (median body mass index [BMI]: 42.9 kg/m(2)) and in 32 healthy, non-obese controls (median BMI: 23.3 kg/m(2)) using a radiometric assay based on the conversion of [(14)C]benzylamine. SSAO and parameters of glucose and lipid metabolism were compared for subgroups of obese patients with normal (n = 49) and impaired (n = 25) glucose tolerance using nonparametric statistical tests. Median SSAO activity was 434 microU/mL in obese patients, which was significantly higher than in healthy, non-obese controls (median SSAO activity: 361 microU/mL). Median SSAO activity in patients with normal and impaired glucose tolerance was 423 and 464 microU/mL, respectively. SSAO activity was not correlated with any other clinical or laboratory parameters characteristic of the metabolic alterations associated with obesity. Elevated SSAO activity is found in nondiabetic, morbidly obese patients and might be an interesting independent risk factor for obesity-related cardiovascular morbidity. Long-term follow-up of SSAO and its possible role in pathogenic events is warranted since intervention with specific SSAO inhibitors is available.
Weiss
H G
HG
Department of General Surgery, University of Innsbruck, Innsbruck, Austria.
Klocker
J
J
Labeck
B
B
Nehoda
H
H
Aigner
F
F
Klingler
A
A
Ebenbichler
C
C
Föger
B
B
Lechleitner
M
M
Patsch
J R
JR
Schwelberger
H G
HG
D000328:Adult; D006631:Amine Oxidase (Copper-Containing) / Q000097:blood*; D002318:Cardiovascular Diseases / Q000209:etiology*; D016022:Case-Control Studies; D005260:Female; D018149:Glucose Intolerance; D006801:Humans; D008297:Male; D009767:Obesity, Morbid / Q000097:blood* / Q000150:complications* / Q000503:physiopathology; D012307:Risk Factors
D006631:Amine Oxidase (Copper-Containing)